Janux Therapeutics Announces Development Candidate Nomination Under Bristol Myers Squibb Collaboration, Triggering $35 Million Milestone Payment
Go back to Janux Therapeutics Announces Development Candidate Nomination Under Bristol Myers Squibb Collaboration, Triggering $35 Million Milestone Payment| Janex International, Inc. (NASDAQ: JANX) | Delayed: 14.92 +0.58 (4.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.34 | 52 Week High | $0.01 | |||
| Open | $14.30 | 52 Week Low | $0.00 | |||
| Day High | $15.01 | P/E | N/A | |||
| Day Low | $14.30 | EPS | $0.00 | |||
| Volume | 846,971 | |||||
